"The Buzz" Show: ADMA Biologics (NASDAQ: ADMA) FDA Approval for IVIG Production Scale | Financial Buzz"The Buzz" Show: ADMA Biologics (NASDAQ: ADMA) FDA Approval for IVIG Production Scale
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “ADMA Biologics Receives FDA Approval for Increased Intravenous Immune Globulin Production Scale” ADMA Biologics (NASDAQ: ADMA), Inc. shot up over 23% in premarket trading after the company was granted approval for an Increased Intravenous Immune Globulin Production Scale by the FDA. The 4,400-liter IVIG plasma pool scale for BIVIGAM® will allow ADMA to expand its manufacturing plant’s total processing capacity from 400,000 liters to an anticipated peak throughput of up to 600,000 liters. ADMA Biologics ...
Source: financialbuzz.com